Truist Securities Raises Price Target on Astrana Health to $59 From $50, Maintains Buy Rating
Astrana Health's Strong Q2 Performance and Strategic Growth Fuel Buy Rating
Does Astrana Health (ASTH) Have a Long Runway for Growth?
Astana Health, Inc. (ASTH) Q2 2024 Earnings Call Transcript
Astrana Health Sees FY24 EPS $1.12-$1.36 Vs $1.42 Est.; Revenue $1.75B-$1.85B Vs $1.76B Est.
Express News | Apollo Medical Holdings Inc FY2024 Shr View $1.42, Rev View $1.76 Bln -- LSEG IBES Data
Express News | Astrana Health, Inc. : Sees FY EPS $1.12-$1.36
Express News | Astrana Health, Inc: Qtrly Total Revenue of $486.3 Mln; Earnings per Share $0.40
Astrana Health 2Q EPS 71c >ASTH
Earnings Flash (ASTH) ASTRANA HEALTH Reports Q2 Revenue $486.3M, Vs. Street Est of $440.8M
Express News | Astrana Health, Inc. Reports Second Quarter 2024 Results
Astrana Health, Inc.'s (NASDAQ:ASTH) P/E Is Still On The Mark Following 29% Share Price Bounce
Astrana Health Is Maintained at Buy by Stifel
Astrana Health Analyst Ratings
Stifel Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $60
Express News | Astrana Health Inc : Stifel Raises Target Price to $60.00 From $48.00
Astrana Health, Inc. (ASTH) Reports Next Week: Wall Street Expects Earnings Growth
Institutional Investors Control 52% of Astrana Health, Inc. (NASDAQ:ASTH) and Were Rewarded Last Week After Stock Increased 7.4%
Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $62
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating